hotspot -WSS

hotspot

author：leisure time 2025-09-14 21:59:07 - browse：7686

STAT's Damian Garde speaks with Mikael Dolsten and Mathai Mammen, in New York on March 21, 2024 — From left to right, STAT's Damian Garde; Mikael Dolsten, chief scientific officer of Pfizer research and development; and Rose Loughlin, Moderna’s senior vice president of early research and development, discuss the future of pharma at the STAT 2024 Breakthrough Summit East. STAT

Drug development is more of a sprint than a marathon these days, thanks to more and better ways to target underlying biology and a more nuanced interpretation of precision medicine, three biotech leaders said at the STAT Breakthrough Summit East in New York Thursday.

“We used to say, well, you may spend five years in the research phase, another five in development. Now I see a project that takes one year of research, from an idea to studies,” said Mikael Dolsten, chief scientific officer and president of Pfizer research and development. “Time is life. You care about patients. And when the distance to run is long, it holds back the energy and the inspiration.”

Key to that success are transformative new technologies like messenger RNA, which powered vaccines developed by Pfizer with its partner BioNTech.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Pharma companies must ensure equitable access to obesity drugs

hotspot

WSS

Key lawmaker blasts Congress’ efforts on addiction: ‘Shame on us’

NIH tests clinical research in primary care with $30 million program

STAT Virtual Event: ASCO Recap, Live!

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

Driven by the pandemic, applicants flood public health schools

Lilly's Alzheimer's drug donanemab backed by FDA advisers

hotspot

hotspot

entertainment

Malaria cases in Florida and Texas: Here’s what you need to know

California wildfire smoke linked to 52,000 early deaths, study says

Virginia high school admissions case could be legal follow

My daughter's legacy lives on through her writing, phage therapy

As demand for Covid shots wanes, Moderna seeks its next success

Stanford president's case begs question: Who takes blame?

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Deposition: Sackler embraced plan to conceal OxyContin’s strength

Medical records are filled with copy

Health care court cases: Humana, Sutter, Novant

knowledge

Indian pharmaceutical industry in denial over drug

A Q&A with Gavi’s Seth Berkley on vaccines, Covid, and more

Vir antibody drug aimed at influenza A fails in clinical trial

Moderna says combo Covid

Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

hotspot

hotspot

hotspot

Wikipedia